ards高危因素課件

ARDS預(yù)防：高危因素評(píng)估和干預(yù)ARDS的柏林定義與診斷標(biāo)準(zhǔn)急性呼吸窘迫綜合征發(fā)病時(shí)機(jī)在已知誘因后，或新出現(xiàn)或原有呼吸系統(tǒng)癥狀加重后一周內(nèi)發(fā)病胸部影像學(xué)a雙肺透光度減低，且不能完全用胸腔積液、肺葉不張或結(jié)節(jié)解釋肺水腫來(lái)源無(wú)法用心功能衰竭或液體負(fù)荷過(guò)多解釋的呼吸衰竭

如果沒(méi)有危險(xiǎn)因素，則需要客觀評(píng)估（如心臟超聲檢查）排除靜水壓升高的肺水腫低氧血癥b輕度：PEEP/CPAP

≥5cmH2O時(shí)200mmHg<PaO2/FiO2≤300mmHgc

中度：PEEP/CPAP

≥5cmH2O時(shí)100mmHg<PaO2/FiO2≤200

mmHg

重度：PEEP/CPAP

≥5cmH2O時(shí)PaO2/FiO2≤100

mmHgCPAP，持續(xù)氣道正壓；PEEP，呼氣末正壓胸片或CT掃描如果海拔超過(guò)1000m，應(yīng)根據(jù)如下公式進(jìn)行校正：[PaO2/FiO2

x(大氣壓/760)]輕度ARDS患者可能接受無(wú)創(chuàng)通氣ARDS/ALI的危險(xiǎn)因素直接間接?肺炎?誤吸?吸入性損傷?肺挫傷?肺血管炎?溺水?脂肪栓塞?肺移植或肺動(dòng)脈取栓術(shù)后再灌注肺水腫?非肺源性膿毒血癥

?創(chuàng)傷?胰腺炎?嚴(yán)重?zé)齻?非心源性休克?藥物過(guò)量?多次輸血（24h內(nèi)大于15u）或輸血相關(guān)性ALI?神經(jīng)源性肺水腫?羊水栓塞?骨髓移植后

Modrykamien,ArielM.,andPoojaGupta."Theacuterespiratorydistresssyndrome."

Proceedings(BaylorUniversity.MedicalCenter)

28.2(2015):163.ARDS與酗酒酗酒與ARDS相關(guān)性研究MoazedF,

CalfeeCS

.Environmental

riskfactors

for

acuterespiratorydistresssyndrome.ClinChestMed.

2014Dec;35(4):625-37.doi:10.1016/j.ccm.2014.08.003.Epub2014Sep30.酗酒引起ARDS的機(jī)制MoazedF,

CalfeeCS

.Environmental

riskfactors

for

acuterespiratorydistresssyndrome.ClinChestMed.

2014Dec;35(4):625-37.doi:10.1016/j.ccm.2014.08.003.Epub2014Sep30.吸煙與ARDS相關(guān)性研究MoazedF,

CalfeeCS

.Environmental

riskfactors

for

acuterespiratorydistresssyndrome.ClinChestMed.

2014Dec;35(4):625-37.doi:10.1016/j.ccm.2014.08.003.Epub2014Sep30.吸煙引起ARDS的機(jī)制MoazedF,

CalfeeCS

.Environmental

riskfactors

for

acuterespiratorydistresssyndrome.ClinChestMed.

2014Dec;35(4):625-37.doi:10.1016/j.ccm.2014.08.003.Epub2014Sep30.【疾病因素】MayoClinic的研究（2015）5584個(gè)患者，其中4646名有SpO2/FiO2記錄FesticE,BansalV,KorDJ,etal.SpO2/FiO2RatioonHospitalAdmissionIsanIndicatorofEarlyAcuteRespiratoryDistressSyndromeDevelopmentAmongPatientsatRisk[J].Journalofintensivecaremedicine,2013:16411.SpO2/FiO2優(yōu)勢(shì)比(OR)P值<1002.49(1.69-3.64)<.001100<2001.75(1.16-2.58)=.007200<3001.62(1.06-2.42)=.025入院后6h內(nèi)的SpO2/FiO2，是ARDS早期的獨(dú)立危險(xiǎn)因素糖尿病與ARDS薈萃分析Gu等，至2013年9月的相關(guān)研究12,794人入選(2,937人既往有糖尿病史，2,457例ALI/ARDS)GuWJ,WanYD,TieHT,etal.Riskofacutelunginjury/acuterespiratorydistresssyndromeincriticallyilladultpatientswithpre-existingdiabetes:ameta-analysis[J].PloSone,2014,9(2):e90426.既往存在糖尿病病史的患者發(fā)生ALI/ARDS的風(fēng)險(xiǎn)降低膿毒癥患者乳酸值升高與發(fā)生ARDS相關(guān)單中心，隨機(jī)研究，778例severesepsisMikkelsenME,ShahCV,MeyerNJ,etal.Theepidemiologyofacuterespiratorydistresssyndromeinpatientspresentingtotheemergencydepartmentwithseveresepsis[J].Shock(Augusta,Ga.),2013,40(5):375-381.膿毒癥患者乳酸值≥2

mmol/L是發(fā)生ARDS的獨(dú)立危險(xiǎn)因素胰腺炎和ARDS胰腺炎和ARDS多因素回歸分析，243例重癥胰腺炎患者10~25%的急性胰腺炎患者發(fā)生ARDS。急性重癥胰腺炎患者發(fā)生ARDS與性別，低蛋白血癥，高甘油三酯存在相關(guān)性

邵斌霞,何斌,劉紅梅,邵旦兵,孫兆瑞,林金鋒,張煒,任藝,聶時(shí)南.急性重癥胰腺炎并發(fā)ARDS多因素回歸分析[J].臨床急診雜志,2014,08:449-451+455.胰腺炎引起ARDS的機(jī)制—肺血管內(nèi)皮屏障破壞，中性粒細(xì)胞浸潤(rùn)損傷肺實(shí)質(zhì)ZhouMT,ChenCS,ChenBC,etal.AcutelunginjuryandARDSinacutepancreatitis:mechanismsandpotentialintervention[J].Worldjournalofgastroenterology:WJG,2010,16(17):2094.胰腺炎引起ARDS的機(jī)制–胃腸道胃腸道通透性增加，細(xì)菌和內(nèi)毒素移位。激活炎癥介質(zhì)，引起SIRS和MODS。ZhouMT,ChenCS,ChenBC,etal.AcutelunginjuryandARDSinacutepancreatitis:mechanismsandpotentialintervention[J].Worldjournalofgastroenterology:WJG,2010,16(17):2094.低蛋白血癥和ARDS低蛋白血癥引起ARDS的機(jī)制血漿膠體滲透壓下降。血液中的水分更易向肺間質(zhì)內(nèi)轉(zhuǎn)移。MangialardiRJ,MartinGS,BernardGR,etal.Hypoproteinemiapredictsacuterespiratorydistresssyndromedevelopment,weightgain,anddeathinpatientswithsepsis[J].Criticalcaremedicine,2000,28(9):3137-3145.其他相關(guān)指標(biāo)LungInjuryPredictionScore（LIPS評(píng)分）誘因LIPS分值休克2誤吸2膿毒癥1肺炎1.5高危手術(shù)a

脊柱急腹癥

心臟主動(dòng)脈血管

122.53.5高危創(chuàng)傷腦外傷煙塵吸入傷淹溺肺挫傷多發(fā)性骨折2221.51.5危險(xiǎn)因素LIPS分值酗酒1肥胖（BMI>30）1低蛋白血癥1化療1FiO2>0.35（>4L/min）2呼吸急促（RR>30bpm）1.5SpO2<95%1酸中毒（pH<7.35）1.5糖尿病b-1a

急診手術(shù)加1.5分.b

僅膿毒癥時(shí)計(jì)算.ReprintedfromGajicetal,2011(33)withpermissionoftheAmericanThoracicSociety.Copyright?AmericanThoracicSociety.TheAmericanJournalofRespiratoryandCriticalCareMedicineisanofficialjournaloftheAmericanThoracicSociety.LIPS≥4分預(yù)測(cè)ARDS

敏感性為0.69

特異性為0.78

陽(yáng)性預(yù)測(cè)值為0.18

陰性預(yù)測(cè)值為0.97GajicO,DabbaghO,ParkPK,AdesanyaA,ChangSY,HouP,AndersonH3rd,HothJJ,MikkelsenME,GentileNT,GongMN,TalmorD,BajwaE,WatkinsTR,FesticE,YilmazM,IscimenR,KaufmanDA,EsperAM,SadikotR,DouglasI,SevranskyJ,MalinchocM.Earlyidenti?cationofpatientsatriskofacutelunginjury:evaluationoflunginjurypredictionscoreinamulticentercohortstudy.AmJRespirCritCareMed2011;183(4):462–470.【如何預(yù)防ARDS】早期發(fā)現(xiàn)存在高危因素的患者依靠評(píng)分LIPS≥4分（陽(yáng)性預(yù)測(cè)值為0.18，陰性預(yù)測(cè)值為0.97）early

acute

lung

injury

scoreEarly

Acute

Lung

Injury

Score由Levitt等人提出包括3部分吸氧濃度（2-6

L/min記1分，>6

L/min記2分）呼吸頻率（≥30次/min記1分）存在免疫抑制（存在記1分）評(píng)分≥2分發(fā)生ALI的敏感性為0.89,特異性為0.75分缺點(diǎn)：?jiǎn)沃行难芯縇evittJE,CalfeeCS,GoldsteinBA,etal.Earlyacutelunginjury:criteriaforidentifyinglunginjurypriortotheneedforpositivepressureventilation.CritCareMed2013;41:1929–1937.改善臨床策略ARDS的時(shí)間特點(diǎn)ARDS很少發(fā)生在疾病之初1。ARDS一般發(fā)生于患者出現(xiàn)高危因素后2-5天2。LevittJE,CalfeeCS,GoldsteinBA,etal.Earlyacutelunginjury:criteriaforidentifyinglunginjurypriortotheneedforpositivepressureventilation.CritCareMed2013;41:1929–1937.GajicO,DabbaghO,ParkPK,etal.Earlyidentificationofpatientsatriskofacutelunginjury:evaluationoflunginjurypredictionscoreinamulticentercohortstudy.AmJRespirCritCareMed2011;183:462–470.呼吸治療早期治療肺不張。減少過(guò)度通氣。對(duì)于低氧飽和度患者改善供氧2。機(jī)械通氣患者爭(zhēng)取早期拔管4。預(yù)防誤吸。KalletRH,MatthayMA.Hyperoxicacutelunginjury.RespirCare2013;58:123–141.AlbertRK.Theroleofventilation-inducedsurfactantdysfunctionandatelectasisincausingacuterespiratorydistresssyndrome.AmJRespirCritCareMed2012;185:702–708.全身治療減少臥床時(shí)間。早期活動(dòng)3。減少神經(jīng)肌肉阻斷劑的使用。嚴(yán)格輸血指證1。盡早治療sepsis2。目標(biāo)液體復(fù)蘇4。GajicO,RanaR,WintersJL,etal.Transfusion-relatedacutelunginjuryinthecriticallyill:prospectivenestedcase–controlstudy.AmJRespirCritCareMed2007;176:886–891.IscimenR,Cartin-CebaR,YilmazM,etal.Riskfactorsforthedevelopmentofacutelunginjuryinpatientswithsepticshock:anobservationalcohortstudy.CritCareMed2008;36:1518–1522.DellingerRP,LevyMM,RhodesA,etal.Survivingsepsiscampaign:internationalguidelinesformanagementofseveresepsisandsepticshock:2012.CritCareMed2013;41:580–637.AlbertRK.Theroleofventilation-inducedsurfactantdysfunctionandatelectasisincausingacuterespiratorydistresssyndrome.AmJRespirCritCareMed2012;185:702–708.肺創(chuàng)傷預(yù)防（CLIP）的評(píng)估表FesticE,KorDJ,GajicO.Preventionofacuterespiratorydistresssyndrome[J].Currentopinionincriticalcare,2015,21(1):82-90.藥物預(yù)防藥物預(yù)防FesticE,KorDJ,GajicO.Preventionofacuterespiratorydistresssyndrome[J].Currentopinionincriticalcare,2015,21(1):82-90.藥物機(jī)制阿司匹林Inhibitionofplatelet-mediatedcyclooxygenasemetabolisminvolvedinbronchoconstrictionandvasoconstrictionandinhibitsplatelet–neutrophil–endothelialinteractions全身使用皮質(zhì)類固醇Multipotent;inhibitinflammatorycytokines;inducedapoptosisofmacrophages;maintainendothelialcellularbarrier吸入肝素InadditiontopotentiatingantithrombinIII,inhibitsadhesionofneutrophilstoendotheliumanddegradesintravascularandbronchialfibrin吸入皮質(zhì)類固醇Sameassystemiccorticosteroids.Intheory,maysparepatientsfromhyperglycemia,myopathy,superinfection,etc.藥物預(yù)防FesticE,KorDJ,GajicO.Preventionofacuterespiratorydistresssyndrome[J].Currentopinioni